TY - JOUR
T1 - A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis
AU - Jahangir, M.
AU - Hussain, I.
AU - Ul Hasan, M.
AU - Haroon, T. S.
PY - 1998
Y1 - 1998
N2 - In this randomized, double-blind study, the efficacy and safety of oral itraconazole (n = 28) and terbinafine (n = 27), each given for 2 weeks, was compared in patients with tinea capitis. Trichophyton violaceum was the major pathogen in both groups (82.1% and 88.9% respectively). The final evaluation at week 12 showed a cure rate of 85.7% and 77.8%, respectively (P > 0.05). Adverse events noted were mild and did not warrant discontinuation of therapy.
AB - In this randomized, double-blind study, the efficacy and safety of oral itraconazole (n = 28) and terbinafine (n = 27), each given for 2 weeks, was compared in patients with tinea capitis. Trichophyton violaceum was the major pathogen in both groups (82.1% and 88.9% respectively). The final evaluation at week 12 showed a cure rate of 85.7% and 77.8%, respectively (P > 0.05). Adverse events noted were mild and did not warrant discontinuation of therapy.
UR - https://www.scopus.com/pages/publications/0031708924
U2 - 10.1046/j.1365-2133.1998.02465.x
DO - 10.1046/j.1365-2133.1998.02465.x
M3 - Article
C2 - 9892912
AN - SCOPUS:0031708924
SN - 0007-0963
VL - 139
SP - 672
EP - 674
JO - British Journal of Dermatology
JF - British Journal of Dermatology
IS - 4
ER -